Kamran Alam, CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc. (TSHA), sold 1,655 shares at $4.52 ($7K) on 2026-02-04, disclosed to the SEC on 2026-02-06.
Open-market sale of $7k TSHA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TSHA | SELL | 2023-08-25 | $77K | — | Filing → |
| TSHA | SELL | 2022-08-24 | $12K | — | Filing → |
| TSHA | SELL | 2022-08-22 | $106K | — | Filing → |